Table 1 Epidemiological characteristics of patients and DBS settings.

From: Usefulness of thalamic beta activity for closed-loop therapy in essential tremor

 

DD

FTM

Mattis

BDI

Left lead

Right lead

PreOp

M12

PreOp

M12

PreOp

M12

Contact

V

PW

Fq

Contact

V

PW

Fq

P1

30

32

0

142

141

17

9

0–

1.5

60

130

8–

1.7

60

130

P2

43

56

36

139

139

5

3

1–

2.8

120

130

9–

2.7

90

130

P3

7

46

14

138

138

ND

2

0–

1.8

60

130

8–

1.3

60

130

P4

44

31

6

141

141

0

2

0–

2.2

60

130

8–

2

60

130

P5

3

34

4

137

132

12

6

2–

1.1

90

130

10–

1.7

60

130

P6

12

50

19

143

142

8

10

1–2–

2.8

90

130

8–

1.3

60

130

P7

44

39

14

134

140

12

19

0–

1

60

140

8–

1.4

60

140

P8

19

44

14

136

136

7

0

0–

1.7

60

130

8–

3.4

60

130

P9

26

32

8

140

142

ND

8

0–

2

60

130

8–

2.3

90

130

P10

12

62

30

139

139

10

5

2–

2.7

90

130

9–

2.7

60

130

M

24.0

42.6

14.5

138.9

139.0

8.9

6.4

/

2.0

75.0

131.0

/

2.1

66

131

SD

15.8

10.9

11.3

2.8

3.1

5.1

5.5

/

0.7

21.2

3.2

/

0.7

12.6

3.2

  1. DD disease duration (years), FTM Fahn, Tolosa and Marin Tremor score before (PreOp) and 12 months after surgery (M12), Mattis Mattis scale, BDI Beck Depression Inventory, Contact contacts used for chronic deep brain stimulation (DBS), V voltage used for chronic DBS, PW pulse width used for chronic DBS, Fq frequency of DBS, M mean, SD standard deviation, ND no data available.